CDKN2A and cancer: Moreover, the unexpected downregulation of CDKN2A despite predictions of upregulation based on bioinformatics models might be attributed to its role in a different cellular context, such as its known tumor-suppressive function in cancer (Morigi, Perico & Benigni, 2018).